Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer

October 3, 2018 Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …
News
5204602349_c87b204860_z

FDA cracks down on e-cig maker Juul in surprise inspection

October 3, 2018 Research and Development FDA, e-cig, juul, surprise inspection, us San Francisco

The US FDA have launched a surprise inspection of e-cigarette maker Juul’s corporate headquarters in San Francisco, having seized thousands …
News

Novartis forge deal with Boston Pharmaceuticals in effort against AMR

October 3, 2018 Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US

Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …
News

Memorial Sloan Kettering Chief resigns from MSD board

October 3, 2018 Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma

Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …
News
4768764591_9e4f7f0eb8_z

Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018 Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …
News
shutterstock_243110086

No link between progression-free survival benefits and improved quality of life, study argues

October 2, 2018 Manufacturing and Production, Research and Development Cancer, clinical trials, pharma

A study of randomised clinical trials, conducted by Canada’s McMaster University and published in the Journal of the American Medical …
News
shutterstock_114045100

African-American enrollment disproportionately high in no-consent trials

October 2, 2018 Manufacturing and Production, Research and Development FDA, clinical trials, pharma, transparency

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …
News
shutterstock_235920349

Are biosimilars key to solving NHS access concerns?

October 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …
Feature
mcewan

Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
News
shutterstock_273326141

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018 Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …
News
mosquito-1016254_1280

Researchers eliminate mosquito population through CRISPR gene editing technology

September 27, 2018 Research and Development crispr, gene editing, imperial college london, malaria, mosquitoes

Researchers at Imperial College London have been able to wipe out a population of mosquitoes through ‘gene drive’ technology. The …
News
life_sciences_scotland_edit

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma

Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …
Appointment
kenneth_c

Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …
News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026